Response to: The use of low-dose quetiapine does not necessarily increase the risk of major adverse cardiovascular events.
- Published in:
- 2023
- By:
- Publication type:
- Letter
Works matching IS 09242708 AND DT 2023 AND VI 35 AND IP 1
Results: 9
1
2
The male–female suicide ratio in Denmark plateaus at 2.7: an opportunity for targeted intervention?
- Published in:
- Acta Neuropsychiatrica, 2023, v. 35, n. 1, p. 61, doi. 10.1017/neu.2023.1
- By:
- Publication type:
- Article
3
The use of low-dose quetiapine does not necessarily increase the risk of major adverse cardiovascular events.
- Published in:
- 2023
- By:
- Publication type:
- Letter
4
Modelling self-diagnosed burnout as a categorical syndrome – CORRIGENDUM.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
5
Modelling self-diagnosed burnout as a categorical syndrome.
- Published in:
- Acta Neuropsychiatrica, 2023, v. 35, n. 1, p. 50, doi. 10.1017/neu.2022.25
- By:
- Publication type:
- Article
6
Decreased sensitivity to antidepressant drugs in Wistar Hannover rats submitted to two animal models of depression.
- Published in:
- Acta Neuropsychiatrica, 2023, v. 35, n. 1, p. 35, doi. 10.1017/neu.2022.24
- By:
- Publication type:
- Article
7
BDNF-related mutations in major depressive disorder: a systematic review.
- Published in:
- Acta Neuropsychiatrica, 2023, v. 35, n. 1, p. 5, doi. 10.1017/neu.2022.22
- By:
- Publication type:
- Article
8
Impact of genetic deletion of MrgD or Mas receptors in depressive-like behaviour in mice.
- Published in:
- Acta Neuropsychiatrica, 2023, v. 35, n. 1, p. 27, doi. 10.1017/neu.2022.20
- By:
- Publication type:
- Article
9
Heterogeneity of lithium effects in the forced swim test, across more than within experiments.
- Published in:
- Acta Neuropsychiatrica, 2023, v. 35, n. 1, p. 59, doi. 10.1017/neu.2022.17
- By:
- Publication type:
- Article